Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
Cancer
|
January 5, 2024
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade
Eric J Miller, Tracy L Rose, Benjamin L Maughan, et al.
Plos One
|
December 31, 2021
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Stephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Plos One
|
June 21, 2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Stephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
Rana R McKay, Bradley A McGregor, Wanling Xie, et al.
British Journal of Cancer
|
October 9, 2018
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
Tracy L Rose, David D Chism, Ajjai S Alva, et al.
Clinical Genitourinary Cancer
|
May 16, 2023
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study
Corbin J Eule, Junxiao Hu, Sulaiman Al-Saad, et al.
European Urology
|
December 13, 2023
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
Wolfgang Beckabir, Sara E Wobker, Jeffrey S Damrauer, et al.
The Journal of Clinical Investigation
|
August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens
Andrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
Urologic Oncology
|
July 1, 2015
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings
Tracy L Rose, Allison M Deal, Ethan Basch, et al.
Cancer Research Communications
|
August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
Cancer
|
January 5, 2024
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade
Eric J Miller, Tracy L Rose, Benjamin L Maughan, et al.
Plos One
|
December 31, 2021
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Stephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Plos One
|
June 21, 2021
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Stephanie I Kim, Andy H Szeto, Katherine P Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)
Rana R McKay, Bradley A McGregor, Wanling Xie, et al.
British Journal of Cancer
|
October 9, 2018
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy
Tracy L Rose, David D Chism, Ajjai S Alva, et al.
Clinical Genitourinary Cancer
|
May 16, 2023
Outcomes of Second-Line Therapies in Patients With Metastatic de Novo and Treatment-Emergent Neuroendocrine Prostate Cancer: A Multi-Institutional Study
Corbin J Eule, Junxiao Hu, Sulaiman Al-Saad, et al.
European Urology
|
December 13, 2023
Spatial Relationships in the Tumor Microenvironment Demonstrate Association with Pathologic Response to Neoadjuvant Chemoimmunotherapy in Muscle-invasive Bladder Cancer
Wolfgang Beckabir, Sara E Wobker, Jeffrey S Damrauer, et al.
The Journal of Clinical Investigation
|
August 16, 2021
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens
Andrew S Truong, Mi Zhou, Bhavani Krishnan, et al.
Urologic Oncology
|
July 1, 2015
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings
Tracy L Rose, Allison M Deal, Ethan Basch, et al.
Cancer Research Communications
|
August 8, 2024
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features
N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, et al.
Page
of 7